National Haemoglobinopathy Reference Laboratory, Oxford Biomedical Research Centre-Haematology Molecular Diagnostic Service, John Radcliffe Hospital, Oxford, UK.
Haematologica. 2012 Mar;97(3):340-3. doi: 10.3324/haematol.2011.055442. Epub 2011 Nov 18.
We investigated whether mutations in the KLF1 gene are associated with increased Hb F levels in ethnically diverse patients referred to our laboratory for hemoglobinopathy investigation. Functionally effective KLF1 mutations were identified in 11 out of 131 adult samples with an elevated Hb F level (1.5-25.0%). Eleven different mutations were identified, 9 of which were previously unreported. KLF1 mutations were not identified in a matched cohort of 121 samples with normal Hb F levels (<1.0%). A further novel KLF1 mutation was also found in a sickle cell disease patient with a Hb F level of 20.3% who had a particularly mild phenotype. Our results indicate KLF1 mutations could make a significant contribution to Hb F variance in malarial regions where hemogobinopathies are common. All the mutations identified were heterozygous providing further in vivo evidence that a single altered KLF1 allele is sufficient to increase Hb F levels.
我们研究了 KLF1 基因突变是否与我们实验室因血红蛋白病检查而被转介的不同种族患者的 Hb F 水平升高有关。在 131 例 Hb F 水平升高(1.5-25.0%)的成年样本中,发现了 11 例具有功能效应的 KLF1 突变。鉴定出 11 种不同的突变,其中 9 种是以前未报告过的。在 121 例 Hb F 水平正常(<1.0%)的匹配样本中未发现 KLF1 突变。在一名 Hb F 水平为 20.3%的镰状细胞病患者中也发现了另一种新的 KLF1 突变,该患者的表型特别轻微。我们的结果表明,KLF1 突变可能对疟疾地区血红蛋白病常见的 Hb F 变异有重要贡献。所有鉴定出的突变均为杂合子,进一步提供了体内证据表明单个改变的 KLF1 等位基因足以增加 Hb F 水平。